Wearable device for fluid removal in heart failure
Part of Heart & circulation, Kidney & urinary clinical trials.
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 79 years old.
- You have heart failure with fluid buildup (swelling, shortness of breath) that is not getting better with at least 80 mg of furosemide (a water pill) each day.
- Your water pill dose has not changed in the last 5 days.
- Your kidney function (eGFR) is between 15 and 89.
- Your blood pressure is at least 100 mmHg (systolic).
- You do not have severe skin conditions on your legs, severe valve problems, or a history of heart transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates how well doctors can assess “fluid congestion” in people with chronic heart failure where the heart’s squeezing is still preserved. It may help improve how patients are monitored during hospital visits.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This trial tests a device that briefly blocks blood flow in a large vein to help your body remove extra fluid, which may improve symptoms like swelling and shortness of breath. It is for people with advanced heart failure who are already in the hospital and need more help with fluid removal.
This trial tests whether using belly pressure and bedside ultrasound can help doctors better manage fluid removal (decongestion) in people hospitalized with heart failure. The goal is to see if this approach leads to better outcomes.
This trial studies a treatment that removes extra fluid through a catheter placed in the abdomen (peritoneal ultrafiltration) for people with “cardio-renal syndrome” (heart and kidney problems together). It may help those who stay congested despite high-dose water pills (diuretics) and have certain heart circulation and fluid signs.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.